<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-21328" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Esophageal Candidiasis</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Robertson</surname>
            <given-names>Kyle D.</given-names>
          </name>
          <aff>McLaren Greater Lansing</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Nagra</surname>
            <given-names>Navroop</given-names>
          </name>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Mehta</surname>
            <given-names>Dhruv</given-names>
          </name>
          <aff>Westchester MC at NY Medical College</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Kyle Robertson declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Navroop Nagra declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Dhruv Mehta declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>31</day>
          <month>7</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-21328.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>The most prevalent cause of infectious esophagitis is esophageal candidiasis. Of patients that have infectious esophagitis, 88% are from Candida albicans, 10% are from herpes simplex virus, and 2% are from cytomegalovirus. Patients with esophageal candidiasis may have a wide range of symptoms or may be asymptomatic. The most common symptoms being dysphagia, odynophagia, and retrosternal pain. This activity reviews the cause, presentation, and diagnosis of esophageal candidiasis and highlights the role of the interprofessional team in its management.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Review the presentation of a patient with esophageal candidiasis.</p></list-item><list-item><p>Describe the workup of a patient with suspected esophageal candidiasis.</p></list-item><list-item><p>Summarize the treatment of esophageal candidiasis.</p></list-item><list-item><p>Explain the importance of interprofessional team strategies for improving care coordination and communication to aid in prompt diagnosis of esophageal candidiasis and improving outcomes in patients diagnosed with the condition.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=21328&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=21328">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-21328.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>The most prevalent cause of infectious esophagitis is esophageal candidiasis. Of patients that have infectious esophagitis, 88% are from Candida albicans, 10% are from herpes simplex virus, and 2% are from cytomegalovirus. Patients with esophageal candidiasis may have a wide range of symptoms or may be asymptomatic. The most common symptoms being dysphagia, odynophagia, and retrosternal pain. Candida infections of the esophagus are considered opportunistic infections and are seen most commonly in immunosuppressed patients. Candida can be part of the normal oral flora. When host defense mechanisms are impaired, this allows for a proliferation of candida on the esophageal mucosa forming adherent plaques. Esophageal candidiasis can is treatable with various forms of oral and intravenous antifungal medications.<xref ref-type="bibr" rid="article-21328.r1">[1]</xref><xref ref-type="bibr" rid="article-21328.r2">[2]</xref></p>
      </sec>
      <sec id="article-21328.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>By far the highest risk factor for developing esophageal candidiasis is impaired cell-mediated immunity. Immunosuppressed patients at risk for esophageal candidiasis include HIV positive and AIDS patients, chemotherapy patients, patients with radiation to the neck region, antibiotic therapy, patients on chronic systemic or topical inhaled corticosteroids, diabetes mellitus, adrenal insufficiency, and advanced age.<xref ref-type="bibr" rid="article-21328.r1">[1]</xref><xref ref-type="bibr" rid="article-21328.r2">[2]</xref>&#x000a0;Studies have shown that the use of proton-pump inhibitors&#x000a0;is also a strong risk factor for esophageal candidiasis in immunocompetent patients.</p>
      </sec>
      <sec id="article-21328.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Studies have not shown a predominance of esophageal candida in either sex. Increasing age, HIV infection and the use of corticosteroids have been found to correlate with candidal esophagitis.&#x000a0; The median age of a person with esophageal candidiasis is 55.5 years. Several studies have shown esophageal&#x000a0;candidiasis incidence rates ranging from 0.32 to 5.2% in the general population. There is a 9.8% prevalence in HIV-positive patients. The risk of esophageal candidiasis increases in HIV patients when the CD4 count is less than 200. The prevalence of esophageal candidiasis in HIV-infected patients appears to be decreasing due to the effectiveness of highly active antiretroviral therapy (HARRT). However, the incidence in non-HIV patients appears to be increasing, possibly due to comorbidities such as diabetes mellitus or from medications such as antibiotics and corticosteroids. Some studies show that smoking tobacco also correlates with developing esophageal candidiasis.<xref ref-type="bibr" rid="article-21328.r2">[2]</xref><xref ref-type="bibr" rid="article-21328.r3">[3]</xref><xref ref-type="bibr" rid="article-21328.r4">[4]</xref></p>
      </sec>
      <sec id="article-21328.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Candida albicans can be part of the normal oral flora. Due to impaired cell-mediated immunity, the esophageal epithelial layer is susceptible to infection and colonization by candida. The candida proliferates and adheres to the esophageal mucosa forming white-yellow plaques. The plaques can be seen on upper endoscopy and do not wash from the mucosa with water irrigation. These plaques can be found diffusely throughout the entire esophagus or localized in the upper, mid, or distal esophagus.<xref ref-type="bibr" rid="article-21328.r2">[2]</xref></p>
      </sec>
      <sec id="article-21328.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>Histologic confirmation of candida in the esophagus is the gold standard for diagnosis. Hematoxylin and eosin stain of biopsies or brushing of esophageal candidiasis almost always show pseudohyphae which is&#x000a0;diagnostic for esophageal candidiasis. The mucosa involved may exhibit desquamated parakeratosis which characteristically has groups of squamous cells that have detached or are in the process of detaching from the main squamous-lined tissue. This finding is not however specific to esophageal candidiasis. Pathology may demonstrate acute inflammation and/or intraepithelial lymphocytosis.<xref ref-type="bibr" rid="article-21328.r2">[2]</xref></p>
      </sec>
      <sec id="article-21328.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Patients with esophageal candidiasis can have a multitude of complaints; however, patients are often asymptomatic. The most common symptoms associated with esophageal candidiasis are dysphagia, odynophagia, and retrosternal chest pain. Odynophagia is considered to be the hallmark of esophageal candidiasis. Other symptoms include abdominal pain, heartburn, weight loss, diarrhea, nausea, vomiting, melena.<xref ref-type="bibr" rid="article-21328.r1">[1]</xref><xref ref-type="bibr" rid="article-21328.r2">[2]</xref></p>
        <p>The only finding may be an associated infection of the oropharynx with candida.</p>
      </sec>
      <sec id="article-21328.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Diagnosing esophageal candidiasis is via upper endoscopic evaluation. Visualizing the candida on the esophageal mucosa as white plaques or exudates confirms the diagnosis.&#x000a0; Plaques and exudates are adherent to the mucosa and do not wash off with water irrigation. There may also be mucosal breaks or ulcerations. Biopsies or brushings of the plaques can undergo testing for histologic confirmation of the infection.<xref ref-type="bibr" rid="article-21328.r1">[1]</xref></p>
      </sec>
      <sec id="article-21328.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Treatment of esophageal candidiasis involves the use of antifungal therapy. Unlike oropharyngeal candidiasis, esophageal candidiasis should always&#x000a0;be treated&#x000a0;with systemic agents and not topical agents. The most commonly used medication to treat esophageal candidiasis is oral fluconazole 200 to 400 mg per day for 14 to 21 days.&#x000a0; If patients cannot tolerate oral intake, then intravenous Fluconazole 400 mg daily can be used and then de-escalated to oral Fluconazole when the patient can tolerate oral medications. Fluconazole 100 to 200 mg three times per week can&#x000a0;be used to&#x000a0;suppress recurrent esophageal candidiasis. Micafungin 150 mg IV daily has been shown to be&#x000a0;non-inferior to fluconazole at 200 mg daily. Itraconazole 200 mg per day orally or Voriconazole 200 mg twice daily for 14 to 21 days are other treatment options. Amphotericin B deoxycholate 0.3 to 0.7 mg/kg daily can be used in patients with refractory candida esophagitis, but it has serious medication side effects and should be avoided if possible. Posaconazole 400 mg twice daily has been effective in refractory esophageal candidiasis&#x000a0;as well. <xref ref-type="bibr" rid="article-21328.r5">[5]</xref><xref ref-type="bibr" rid="article-21328.r6">[6]</xref><xref ref-type="bibr" rid="article-21328.r7">[7]</xref>&#x000a0;</p>
        <p>One may also use caspofungin as it is preferred over amphotericin.</p>
        <p>Since esophageal candidiasis is an opportunistic infection and most often seen in immunocompromised persons, the cause of the immunosuppression should be diagnosed and treated&#x000a0;as well.<xref ref-type="bibr" rid="article-21328.r8">[8]</xref><xref ref-type="bibr" rid="article-21328.r9">[9]</xref><xref ref-type="bibr" rid="article-21328.r10">[10]</xref></p>
        <p>Patients who are immunosuppressed and have symptoms of odynophagia or dysphagia can empirically be treated with a 14-21 day course of antifungal therapy. If no improvement in symptoms is seen after 72 hours of treatment then upper endoscopy should be performed.<xref ref-type="bibr" rid="article-21328.r11">[11]</xref>&#x000a0;</p>
        <p>The dose of the azole agents does need modification in patients with renal insufficiency.</p>
        <p>Azoles are considered teratogenic, so in pregnant patients with esophageal candidiasis, Amphotericin&#x000a0;B is preferred.</p>
      </sec>
      <sec id="article-21328.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Other common causes of esophagitis are&#x000a0;as follows:<xref ref-type="bibr" rid="article-21328.r1">[1]</xref><xref ref-type="bibr" rid="article-21328.r12">[12]</xref><xref ref-type="bibr" rid="article-21328.r13">[13]</xref></p>
        <list list-type="bullet">
          <list-item>
            <p>Cytomegalovirus</p>
          </list-item>
          <list-item>
            <p>Herpes simplex virus</p>
          </list-item>
          <list-item>
            <p>Eosinophilic esophagitis</p>
          </list-item>
          <list-item>
            <p>Pill-induced esophagitis</p>
          </list-item>
          <list-item>
            <p>Gastroesophageal reflux disease</p>
          </list-item>
          <list-item>
            <p>Radiation esophagitis</p>
          </list-item>
          <list-item>
            <p>Bacterial esophagitis (from <italic toggle="yes">Lactobacillus</italic>, B-hemolytic streptococci, <italic toggle="yes">Cryptosporidium</italic>, <italic toggle="yes">Pneumocystis carinii</italic>, <italic toggle="yes">Mycobacterium avium</italic> complex, <italic toggle="yes">Nocardia</italic>, <italic toggle="yes">Mycobacterium tuberculosis</italic>, <italic toggle="yes">Leishmania donovani)</italic></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-21328.s11" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>There are no specific papers discussing the prognosis of esophageal candidiasis. It is usually treated successfully with antifungal agents. Resistant and refractory infections can occur and may require alternative agents for treatment or long term antifungal prophylaxis to reduce recurrence.<xref ref-type="bibr" rid="article-21328.r7">[7]</xref></p>
      </sec>
      <sec id="article-21328.s12" sec-type="Complications">
        <title>Complications</title>
        <p>Esophageal candidiasis complications include esophageal ulcerations with potential for esophageal perforation and upper gastrointestinal bleeding, weight loss, malnourishment, sepsis, candidemia, esophageal stricture, fistula formation into a bronchial tree.<xref ref-type="bibr" rid="article-21328.r14">[14]</xref><xref ref-type="bibr" rid="article-21328.r15">[15]</xref><xref ref-type="bibr" rid="article-21328.r16">[16]</xref><xref ref-type="bibr" rid="article-21328.r2">[2]</xref></p>
      </sec>
      <sec id="article-21328.s13" sec-type="Postoperative and Rehabilitation Care">
        <title>Postoperative and Rehabilitation Care</title>
        <p>When patients are treated with azoles, there is a risk of liver damage; hence liver function tests should be regularly monitored. Long term treatment is rarely required except in patients who are immunosuppressed.</p>
      </sec>
      <sec id="article-21328.s14" sec-type="Consultations">
        <title>Consultations</title>
        <p>Since upper endoscopy is a requirement for tissue sampling or brushing of the candida plaques in the esophagus, a gastroenterologist or general surgeon would be required to perform the procedure. A pathologist will make the diagnosis of esophageal candidiasis through histologic staining. Infectious disease specialists may be needed to help with treating refractory or recurrent esophageal candidiasis. Infectious disease physicians can also manage the patient's treatment for concomitant HIV which is causing their immunosuppression. Hematology/oncology specialists may also be consulted to manage&#x000a0;patients with immunosuppression or manage chemotherapy medications which are causing immunosuppression.</p>
      </sec>
      <sec id="article-21328.s15" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Since candida is a normal oral flora that proliferates in immunocompromised states of health, one way of decreasing the risk of esophageal candidiasis is to improve health conditions that can cause immunosuppression. Decreasing the use of antibiotics, systemic steroids, and the proper use of inhaled steroids can also be used to limit the risk of esophageal candidiasis. Prophylactic fluconazole may be necessary for patients that have recurrent infections.<xref ref-type="bibr" rid="article-21328.r2">[2]</xref></p>
      </sec>
      <sec id="article-21328.s16" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>There may be some coordinated care between physicians in regard to interprofessional communications when it comes to dealing with esophageal candidiasis. A gastroenterologist or general surgeon may perform the upper endoscopy required for biopsies and brushings of the esophagus. A pathologist will confirm the diagnosis through histology. Most healthcare professionals feel comfortable treating esophageal candidiasis. The primary care provider including the pharmacist must emphasize medication compliance for a cure. In addition, the clinicians should monitor liver function and adjust the dose according to renal insufficiency. The infectious disease nurse must ensure that HIV patients on HAART otherwise the treatment is prolonged and often ineffective.&#x000a0;&#x000a0; If patients have recurrent infections or infections refractory to treatment, then an infectious disease specialist may help. Pharmacists can also help with dosing guidelines. Also, coordinating care with other specialists may be important when managing the causes of immunosuppression. These patients need long term monitoring to ensure cure. Open communication between the team members is vital to ensure good outcomes.</p>
      </sec>
      <sec id="article-21328.s17">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=21328&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=21328">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/infectious-disease/esophageal-candidiasis-yeast-infection-of-the-esophagus/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=21328">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/21328/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=21328">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-21328.s18">
        <fig id="article-21328.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Candida esophagitis Image courtesy S Bhimji MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="candida__esophagitis" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-21328.s19">
        <fig id="article-21328.image.f2" position="float" orientation="portrait">
          <caption>
            <p>Candida albicans Image courtesy S.Bhimji MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="candida" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-21328.s20">
        <fig id="article-21328.image.f3" position="float" orientation="portrait">
          <caption>
            <p>Esophageal Candidiasis James Heilman, MD [CC BY-SA 3.0 (https://creativecommons.org/licenses/by-sa/3.0)]
https://commons.wikimedia.org/wiki/File:Esophageal_Candidiasis2010.JPG</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="image__1" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-21328.s21">
        <title>References</title>
        <ref id="article-21328.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Roso&#x00142;owski</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kierzkiewicz</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Etiology, diagnosis and treatment of infectious esophagitis.</article-title>
            <source>Prz Gastroenterol</source>
            <year>2013</year>
            <volume>8</volume>
            <issue>6</issue>
            <fpage>333</fpage>
            <page-range>333-7</page-range>
            <pub-id pub-id-type="pmid">24868280</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21328.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Alsomali</surname>
                <given-names>MI</given-names>
              </name>
              <name>
                <surname>Arnold</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Frankel</surname>
                <given-names>WL</given-names>
              </name>
              <name>
                <surname>Graham</surname>
                <given-names>RP</given-names>
              </name>
              <name>
                <surname>Hart</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Lam-Himlin</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Naini</surname>
                <given-names>BV</given-names>
              </name>
              <name>
                <surname>Voltaggio</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Arnold</surname>
                <given-names>CA</given-names>
              </name>
            </person-group>
            <article-title>Challenges to "Classic" Esophageal Candidiasis: Looks Are Usually Deceiving.</article-title>
            <source>Am J Clin Pathol</source>
            <year>2017</year>
            <month>Jan</month>
            <day>01</day>
            <volume>147</volume>
            <issue>1</issue>
            <fpage>33</fpage>
            <page-range>33-42</page-range>
            <pub-id pub-id-type="pmid">28158394</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21328.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Takahashi</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Nagata</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Shimbo</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Nishijima</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Watanabe</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Aoki</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Sekine</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Okubo</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Watanabe</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Sakurai</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Yokoi</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Kobayakawa</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Yazaki</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Teruya</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Gatanaga</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Kikuchi</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Mine</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Igari</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Takahashi</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Mimori</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Oka</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Akiyama</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Uemura</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Long-Term Trends in Esophageal Candidiasis Prevalence and Associated Risk Factors with or without HIV Infection: Lessons from an Endoscopic Study of 80,219 Patients.</article-title>
            <source>PLoS One</source>
            <year>2015</year>
            <volume>10</volume>
            <issue>7</issue>
            <fpage>e0133589</fpage>
            <pub-id pub-id-type="pmid">26208220</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21328.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Choi</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>CG</given-names>
              </name>
              <name>
                <surname>Lim</surname>
                <given-names>YJ</given-names>
              </name>
              <name>
                <surname>Kang</surname>
                <given-names>HW</given-names>
              </name>
              <name>
                <surname>Lim</surname>
                <given-names>CY</given-names>
              </name>
              <name>
                <surname>Choi</surname>
                <given-names>JS</given-names>
              </name>
            </person-group>
            <article-title>Prevalence and risk factors of esophageal candidiasis in healthy individuals: a single center experience in Korea.</article-title>
            <source>Yonsei Med J</source>
            <year>2013</year>
            <month>Jan</month>
            <day>01</day>
            <volume>54</volume>
            <issue>1</issue>
            <fpage>160</fpage>
            <page-range>160-5</page-range>
            <pub-id pub-id-type="pmid">23225813</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21328.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Walsh</surname>
                <given-names>TJ</given-names>
              </name>
              <name>
                <surname>Hamilton</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Belitsos</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Esophageal candidiasis. Managing an increasingly prevalent infection.</article-title>
            <source>Postgrad Med</source>
            <year>1988</year>
            <month>Aug</month>
            <volume>84</volume>
            <issue>2</issue>
            <fpage>193</fpage>
            <page-range>193-6, 201-5</page-range>
            <pub-id pub-id-type="pmid">3041396</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21328.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Klotz</surname>
                <given-names>SA</given-names>
              </name>
            </person-group>
            <article-title>Oropharyngeal candidiasis: a new treatment option.</article-title>
            <source>Clin Infect Dis</source>
            <year>2006</year>
            <month>Apr</month>
            <day>15</day>
            <volume>42</volume>
            <issue>8</issue>
            <fpage>1187</fpage>
            <page-range>1187-8</page-range>
            <pub-id pub-id-type="pmid">16575740</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21328.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pappas</surname>
                <given-names>PG</given-names>
              </name>
              <name>
                <surname>Kauffman</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Andes</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>Clancy</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Marr</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Ostrosky-Zeichner</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Reboli</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Schuster</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Vazquez</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Walsh</surname>
                <given-names>TJ</given-names>
              </name>
              <name>
                <surname>Zaoutis</surname>
                <given-names>TE</given-names>
              </name>
              <name>
                <surname>Sobel</surname>
                <given-names>JD</given-names>
              </name>
            </person-group>
            <article-title>Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America.</article-title>
            <source>Clin Infect Dis</source>
            <year>2016</year>
            <month>Feb</month>
            <day>15</day>
            <volume>62</volume>
            <issue>4</issue>
            <fpage>e1</fpage>
            <page-range>e1-50</page-range>
            <pub-id pub-id-type="pmid">26679628</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21328.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Skiest</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Vazquez</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Anstead</surname>
                <given-names>GM</given-names>
              </name>
              <name>
                <surname>Graybill</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Reynes</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Ward</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Hare</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Boparai</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Isaacs</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Posaconazole for the treatment of azole-refractory oropharyngeal and esophageal candidiasis in subjects with HIV infection.</article-title>
            <source>Clin Infect Dis</source>
            <year>2007</year>
            <month>Feb</month>
            <day>15</day>
            <volume>44</volume>
            <issue>4</issue>
            <fpage>607</fpage>
            <page-range>607-14</page-range>
            <pub-id pub-id-type="pmid">17243069</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21328.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lake</surname>
                <given-names>DE</given-names>
              </name>
              <name>
                <surname>Kunzweiler</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Beer</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Buell</surname>
                <given-names>DN</given-names>
              </name>
              <name>
                <surname>Islam</surname>
                <given-names>MZ</given-names>
              </name>
            </person-group>
            <article-title>Fluconazole versus amphotericin B in the treatment of esophageal candidiasis in cancer patients.</article-title>
            <source>Chemotherapy</source>
            <year>1996</year>
            <season>Jul-Aug</season>
            <volume>42</volume>
            <issue>4</issue>
            <fpage>308</fpage>
            <page-range>308-14</page-range>
            <pub-id pub-id-type="pmid">8804799</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21328.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>de Wet</surname>
                <given-names>NT</given-names>
              </name>
              <name>
                <surname>Bester</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Viljoen</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Filho</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Suleiman</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Ticona</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Llanos</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>Fisco</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Lau</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Buell</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>A randomized, double blind, comparative trial of micafungin (FK463) vs. fluconazole for the treatment of oesophageal candidiasis.</article-title>
            <source>Aliment Pharmacol Ther</source>
            <year>2005</year>
            <month>Apr</month>
            <day>01</day>
            <volume>21</volume>
            <issue>7</issue>
            <fpage>899</fpage>
            <page-range>899-907</page-range>
            <pub-id pub-id-type="pmid">15801925</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21328.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Benson</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Kaplan</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Masur</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Pau</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Holmes</surname>
                <given-names>KK</given-names>
              </name>
              <collab>CDC</collab>
              <collab>National Institutes of Health</collab>
              <collab>Infectious Diseases Society of America</collab>
            </person-group>
            <article-title>Treating opportunistic infections among HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association/Infectious Diseases Society of America.</article-title>
            <source>MMWR Recomm Rep</source>
            <year>2004</year>
            <month>Dec</month>
            <day>17</day>
            <volume>53</volume>
            <issue>RR-15</issue>
            <fpage>1</fpage>
            <page-range>1-112</page-range>
            <pub-id pub-id-type="pmid">15841069</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21328.r12">
          <label>12</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Antunes</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Sharma</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <chapter-title>Esophagitis</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>8</month>
            <day>7</day>
            <pub-id pub-id-type="pmid">28723041</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21328.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Geagea</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Cellier</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Scope of drug-induced, infectious and allergic esophageal injury.</article-title>
            <source>Curr Opin Gastroenterol</source>
            <year>2008</year>
            <month>Jul</month>
            <volume>24</volume>
            <issue>4</issue>
            <fpage>496</fpage>
            <page-range>496-501</page-range>
            <pub-id pub-id-type="pmid">18622166</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21328.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ostrosky-Zeichner</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Rex</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Bennett</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kullberg</surname>
                <given-names>BJ</given-names>
              </name>
            </person-group>
            <article-title>Deeply invasive candidiasis.</article-title>
            <source>Infect Dis Clin North Am</source>
            <year>2002</year>
            <month>Dec</month>
            <volume>16</volume>
            <issue>4</issue>
            <fpage>821</fpage>
            <page-range>821-35</page-range>
            <pub-id pub-id-type="pmid">12512183</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21328.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lee</surname>
                <given-names>KJ</given-names>
              </name>
              <name>
                <surname>Choi</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>WS</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Moon</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Ko</surname>
                <given-names>JS</given-names>
              </name>
            </person-group>
            <article-title>Esophageal Stricture Secondary to Candidiasis in a Child with Glycogen Storage Disease 1b.</article-title>
            <source>Pediatr Gastroenterol Hepatol Nutr</source>
            <year>2016</year>
            <month>Mar</month>
            <volume>19</volume>
            <issue>1</issue>
            <fpage>71</fpage>
            <page-range>71-5</page-range>
            <pub-id pub-id-type="pmid">27066451</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21328.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Aghdam</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Sund</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Invasive Esophageal Candidiasis with Chronic Mediastinal Abscess and Fatal Pneumomediastinum.</article-title>
            <source>Am J Case Rep</source>
            <year>2016</year>
            <month>Jul</month>
            <day>08</day>
            <volume>17</volume>
            <fpage>466</fpage>
            <page-range>466-71</page-range>
            <pub-id pub-id-type="pmid">27389822</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
